Filing Details

Accession Number:
0000899243-21-025423
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-22 20:11:00
Reporting Period:
2021-06-17
Accepted Time:
2021-06-22 20:11:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1680367 Shattuck Labs Inc. STTK Pharmaceutical Preparations (2834) 812575858
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1827315 Josiah Hornblower C/O Shattuck Labs, Inc.
500 W. 5Th Street, Suite 1200
Austin TX 78701
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-17 8,469 $28.76 3,098,942 No 4 S Indirect By Hornblower Capital Holdings, LLC
Common Stock Disposition 2021-06-18 9,840 $29.00 3,089,102 No 4 S Indirect By Hornblower Capital Holdings, LLC
Common Stock Disposition 2021-06-20 7,382 $29.96 3,081,720 No 4 S Indirect By Hornblower Capital Holdings, LLC
Common Stock Disposition 2021-06-21 9,245 $29.82 3,072,475 No 4 S Indirect By Hornblower Capital Holdings, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Hornblower Capital Holdings, LLC
No 4 S Indirect By Hornblower Capital Holdings, LLC
No 4 S Indirect By Hornblower Capital Holdings, LLC
No 4 S Indirect By Hornblower Capital Holdings, LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2021-06-19 3,434 $0.00 3,434 $29.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,434 2031-06-19 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 79,356 Indirect By Stone Dock Investors
Footnotes
  1. This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $27.635 to $29.70. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $27.82 to $30.02. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $29.29 to $30.575. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $29.08 to $31.05. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This option represents a right to purchase a total of 3,434 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.